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Abstract
Preterm birth (PTB) represents the leading cause of neonatalBackground: 
death. Large-scale genetic studies are necessary to determine genetic
influences on PTB risk, but prospective cohort studies are expensive and
time-consuming. We investigated the feasibility of retrospective recruitment
of post-partum women for efficient collection of genetic samples, with
self-collected saliva for DNA extraction from themselves and their babies,
alongside self-recollection of pregnancy and birth details to phenotype
PTB.
708 women who had participated in the OPPTIMUM trial (aMethods: 
randomised trial of progesterone pessaries to prevent PTB
[ISRCTN14568373]) and consented to further contact were invited to
provide self-collected saliva from themselves and their babies. DNA was
extracted from Oragene OG-500 (adults) and OG-575 (babies) saliva kits
and the yield measured by Qubit. Samples were analysed using a panel of
Taqman single nucleotide polymorphism (SNP) assays. A questionnaire
designed to meet the minimum data set required for phenotyping PTB was
included. Questionnaire responses were transcribed and analysed for
concordance with prospective trial data.
Recruitment rate was 162/708 (23%) for self-collected salivaResults: 
samples and 157/708 (22%) for questionnaire responses. 161 samples
from the mother provided DNA with median yield 59.0µg (0.4-148.9µg). 156
samples were successfully genotyped (96.9%). 136 baby samples had a
median yield 11.5µg (0.1-102.7µg); two samples failed DNA extraction. 131
baby samples (96.3%) were successfully genotyped. Concordance
between self-recalled birth details and prospective birth details ranged from
55 – 99%, median 86%. The highest rates of concordance were found for
mode of birth (154/156 [99%]), smoking status (151/157 [96%]) and
ethnicity (149/156 [96%]).
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 ethnicity (149/156 [96%]).
This feasibility study demonstrates that self-collected DNAConclusion: 
samples from mothers and babies were sufficient for genetic analysis but
yields were variable. Self-recollection of pregnancy and birth details was
inadequate for accurately phenotyping PTB, highlighting the need for
alternative strategies for investigating genetic links with PTB.
Keywords
premature birth, fetal membranes, premature rupture, obstetric labour,
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Introduction
Preterm birth is the leading cause of neonatal morbidity and 
mortality, resulting in an estimated economic burden to the 
public sector in England and Wales in excess of £2.9 billion 
over 18 years1. Spontaneous preterm birth (PTB) refers to 
birth less than 37 weeks gestation after the spontaneous onset 
of contractions2. In England in 2011/2012 27,509 babies 
were spontaneous PTBs, of which 11,480 were less than 
32 weeks gestation3. Although our knowledge surrounding PTB 
and thus our ability to treat and prevent it has been increas-
ing over time, 95% of preterm births are intractable to cur-
rent therapies4. Thus, further research into the pathogenesis of 
PTB is required to decrease this public health problem.
Research has shown that genetic factors contribute to sponta-
neous PTB. The strongest risk factor for PTB is a history of 
PTB2,5, with a recurrence rate after one spontaneous PTB of 
15%, which further increases the earlier the gestation, suggest-
ing a maternal genetic component to the risk. Another sugges-
tion of genetic association is the significant ethnic differences in 
incidence of PTB, with higher rates in women classified as 
black, African-American and Afro-Caribbean compared with 
white women, even when environmental confounding factors 
are taken into consideration2. A familial predisposition has also 
been shown, with women who were born preterm being more 
likely to have preterm babies themselves6, as well as women 
being more likely to have PTB if their sisters have had PTB7,8.
Recent advances in genetic and bioinformatic technologies 
now provide the potential to understand the complex interac-
tion of genetic and environmental factors. However, studies 
of genetic associations with pregnancy complications are depend-
ent on very large numbers of good quality DNA samples from 
well-phenotyped cases, preferably with samples from mother 
and baby pairs. Studies of genetic associations with conditions 
such as breast cancer and diabetes have successfully used postal 
recruitment, with participants donating DNA through provision 
of saliva samples, which can be returned by post9. This method 
could be an efficient way of sample collection from women 
who have had a PTB and their babies. However, it is crucial to 
know whether high quality phenotypic information can be pro-
vided alongside this approach. An international collaboration of 
researchers interested in genetic epidemiology studies of preg-
nancy has highlighted prerequisite phenotypic information essen-
tial for performing genetic association studies of preterm birth10. 
The group highlights the important differences between spon-
taneous PTB (spontaneous onset of contractions), spontaneous 
PTB with preterm premature rupture of membranes (PPROM), 
and medically indicated PTB (medical indications being fetal 
compromise, such as small for gestational age, or maternal 
compromise, for example severe pre-eclampsia)11. The genetic 
associations and pathophysiology underlying these three con-
ditions vary greatly11, hence the necessity for accurate pheno-
typing in genetic studies in this field specifically. Furthermore, 
it has not yet been established if maternal recall would be of 
sufficient quality to support such research. It is also unknown 
whether postal recruitment and self-collection of samples from 
mothers, and maternal collection of samples from infants, 
would be acceptable to participants or yield sufficient quantity 
and quality of DNA.
There are three aims of this study, which was completed in col-
laboration with mother and baby pairs from women who took 
part in the OPPTIMUM trial12. Firstly, to pilot the method of 
postal recruitment and sample collection, return and processing. 
Secondly, to confirm that maternally collected saliva samples, 
particularly from infants, provide sufficient high quality DNA 
yield. Thirdly, to assess the agreement of self-recalled preg-
nancy and birth details in a questionnaire, including essential 
information for preterm birth genetic association studies, 
compared with prospectively collected OPPTIMUM trial data.
Methods
Participants
We included UK based participants from the OPPTIMUM trial, 
a double-blind, randomised, placebo-controlled trial investigat-
ing the effect of vaginal progesterone on pregnancy and infant 
outcomes in women at high risk of spontaneous PTB (https:// 
doi.org/10.1186/ISRCTN14568373)12. OPPTIMUM recruited 
from 65 UK National Health Service (NHS) Hospitals and 1 
Swedish hospital between February 2009 and April 2013. The 
inclusion criteria for the OPPTIMUM trial were: high risk for 
PTB, gestation established by scan at ≤ 16 weeks to ensure that 
estimated date of delivery is accurate, signed consent form and 
aged 16 years or older (no upper age limit). Exclusion criteria 
for the OPPTIMUM trial were: known significant congenital 
structural or chromosomal fetal anomaly, known sensitivity, con-
traindication or intolerance to progesterone, suspected or proven 
rupture of the fetal membranes at the time of recruitment, multiple 
pregnancy, prescription or ingestion of medications known to 
interact with progesterone and women who were prescribed 
progesterone who took progesterone beyond 18 weeks ges-
tation (See extended data: Appendix 213). For this study, we 
excluded women who: had withdrawn their consent from 
the OPPTIMUM trial, those of whom we had no contact 
details, those whose babies had died subsequent to the 2-year 
follow-up period, and those who were recruited in Sweden 
(Figure 1).
Recruitment
Potential participants were sent a letter of invitation to the 
“OPPTIMUM genetics” study from 20th April 2015 to 23rd July 
2015 (see extended data13). Women who had a stillbirth, neo-
natal or infant death were sent an alternate letter of invitation 
(see extended data13). Women were asked to reply by email, 
phone, text or post to indicate their interest in participating. 
The study lasted for 12 months after the last recruitment pack 
was sent out.
Sample collection
Women who responded positively to the invitation letter were 
sent a recruitment pack (see extended data: Appendix 313). 
Women who had a live infant were invited to provide a saliva 
sample from themselves and their baby born whilst participating 
in the OPPTIMUM study; for those women who had 
experienced infant loss, an alternative pack was sent with a 
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Figure 1. Study flow diagram of recruitment.
collection kit for themselves only. The recruitment packs con-
tained a recruitment letter, patient information leaflet, maternal 
consent form (2 copies), child assent form (if child over 4 years 
old), instructions for saliva sample collection for mother and 
maternal saliva sample collection kit (Oragene OG-500, DNA 
Genotek), a clinical data questionnaire and a postal return 
kit (postage paid; see extended data13). Where appropriate, 
instructions for saliva sample collection for baby, and an 
infant saliva sample collection kit (Oragene OG-575, DNA 
Genotek) was included. If the participant’s baby had died, they 
were invited to provide a saliva sample from themselves, and 
an alternative recruitment pack was sent (see extended data: 
Appendix 313). Women who had not returned the recruitment 
pack after 6–8 weeks were sent a single reminder letter.
Questionnaire design and application
The questionnaire was designed by the OPPTIMUM trial team 
to meet the minimum data required for a study of PTB14 and 
was piloted in 20 postpartum women. It included questions on 
gestation at birth, maternal age at birth, birth method, labour 
onset, membrane rupture, maternal smoking, non-prescription 
drug use and alcohol intake, as well as the number of previ-
ous pregnancies and maternal ethnic origin (see extended data: 
Appendix 113). Participants were asked to answer the questions 
in relation to their pregnancy during the OPPTIMUM trial.
Receipt, processing and storage of samples
The Edinburgh Clinical Research Facility Genetics Core received 
and processed the samples. Samples were identified by the 
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OPPTIMUM trial number, with a suffix for mother and baby 
and labelled with details readable by barcode scanner.
DNA extraction and validation
DNA was extracted from Oragene OG-500 (adults) and OG-575 
(babies) saliva kits using Oragene prepIT (PT-L2P-5) extrac-
tion kit (supplied by DNA Genotek). DNA yield was measured 
by Qubit (ThermoFisher). Samples were genotyped on a panel 
of Taqman single nucleotide polymorphisms (SNPs) using the 
QuantStudio12K Flex and analysed using QuantStudio v1.2.2 
software. Samples from mothers were genotyped using auto-
somal SNPs rs6427699, rs4751955, rs11083515, rs7588807, 
rs10938367 & rs10869955. Samples from babies were run on the 
same six autosomal SNPs and an additional three SNPs from the 
Y-chromosome to determine sex (rs2032598, rs768983 & 
rs3913290). An aliquot of DNA was normalised in plates for 
future analysis. DNA samples were transferred for storage and 
used as part of the Edinburgh Reproductive Tissues Biobank 
(REC reference 09/S0704/3).
Data analysis
For this study, data was transcribed from the questionnaires 
and appropriate information was obtained from the trial 
database. Patient identifiable information was removed and 
trial data was correlated with the corresponding questionnaire 
through randomised OPPTIMUM trial numbers. In keeping with 
the Caldicott principles15, access to trial data was only granted 
to members of the research team, and stored on a password 
protected database on a secure server (University of Edinburgh). 
The concordance between self-recalled birth details and 
prospective trial birth details was then analysed for gestation 
at birth, maternal age at birth, mode of birth, onset of labour, 
smoking, non-prescription drug use, alcohol use and number of 
previous pregnancies. The concordance for PPROM was analysed 
in women who had a PTB. We pre-specified that a participa-
tion rate of ≥ 50% would be acceptable and concordance of 
≥ 95% between self-recalled birth details and prospective trial 
birth details would be sufficient for phenotyping PTB. These 
values were chosen by the research team as previous studies of 
self-collected DNA samples have had participation rates above 
50%16,17 and accurate recall using patient questionnaires would 
be necessary for any future large scale studies using this design.
Statistical analysis
All data was analysed using IBM Statistical Package for the 
Social Sciences (SPSS) Version 22. Normally distributed data 
was analysed using a t-test. The Fishers exact test was used 
for proportional data. A p-value of <0.05 was considered 
significant.
Ethical opinion
This study was awarded a favourable ethical opinion by the 
regional ethics committee (REC reference 14/SS/0086).
Results
Recruitment rate and participant demographics
In total, 708 women were contacted. From these, 157 question-
naires were returned, a participation rate of 22%. Overall, 299 
DNA sample kits were received (137 mother and baby paired 
samples, 24 mother only samples, 1 baby only sample) - a partic-
ipation rate of 162/708 (23%) (see Figure 1). Seven participants 
returned a DNA sample kit without a questionnaire and 2 par-
ticipants returned the questionnaire without a DNA sample. One 
participant was recruited twice to the OPPTIMUM trial and so 
returned a questionnaire for each pregnancy, a mother and baby 
paired sample from her first child and a baby only sample from 
her second child. See underlying data for all data collected13.
The demographics of the questionnaire respondents are 
shown in Table 1. To determine if these 157 women were 
representative of the OPPTIMUM trial population the demo-
graphics of the participants in this pilot study were compared 
to that of the entire cohort of OPPTIMUM trial participants. 
This highlighted that the pilot study participants were signifi-
cantly older, more educated, had a higher proportion of white 
participants, and a lower proportion of black participants 
compared with the entire OPPTIMUM cohort (Table 1).
DNA extraction and quality assessment
DNA was extracted from 299 saliva samples. All 161 sam-
ples from the mother provided DNA with median yield 59.0µg 
(0.4–148.9µg). Two baby samples failed and provided no DNA. 
The remaining 136 baby samples had a median yield 11.5µg 
(0.1–102.7µg) (Table 2). Samples were genotyped using 
a panel of six autosomal Taqman SNPs and were deemed 
suitable for genomic analysis if they successfully genotyped 
on five or more SNPs. 156 of the 161 samples (96.9%) from the 
mother successfully genotyped (one sample failed on four SNPs, 
three samples failed on five SNPs and one sample failed 
on all six SNPs). 131 of the 136 baby samples (96.3%) 
successfully genotyped (three samples failed on five SNPs and 
two samples failed on all six SNPs) (Table 2).
The baby samples were additionally genotyped on three 
Y-chromosome SNPs. Samples that successfully called on five or 
six autosomal SNPs were checked for sex, with samples having a 
no-call on all three Y-chromosomes SNPs determined as female 
and samples having a call on all three Y-chromosome SNPs 
determined as male. Samples having a positive call on only one 
or two Y-chromosome SNPs were assigned to ‘unknown’, of 
which 5 of 131 samples were assigned. Additionally, 2 samples 
did not have matched trial data to verify sex. In total, 121 of 
124 samples (97.6%) correctly identified the sex of the baby; 
3 samples which were assumed female from genotyping were 
male (Table 2).
Concordance of self-recalled birth details and prospective 
trial birth details
Concordance of self-recalled birth details and prospective 
trial birth details for each variable are displayed in Table 3 
and Figure 2. Concordance ranged from 55% for PPROM to 
99% for mode of birth. Median concordance was 86%. Overall, 
concordance of self-recalled birth details and prospective trial 
birth details was only greater than 95% in 3 out of 10 key fields 
for phenotyping PTB (mode of birth, smoking status and 
ethnicity).
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Table 2. Results of DNA analysis and genotyping from mother and baby self-
collected saliva samples.
Mother samples 
(n=161)
Baby samples 
(n=138)
Number of samples suitable for analysis 161 (100%) 136 (98.6%)
Median DNA yield in μg (range) 59.0 (0.4-148.9) 11.5 (0.1-102.7)
Number of samples successfully genotyped 
using 6 autosomes
156/161 (96.9%) 131/136 (96.3%)
Number of samples correctly identifying sex 121/124 (97.6%)
Table 1. Demographics of study participants.
Pilot study OPPTIMUM trial 
cohort
N n (%) or 
mean (SD)
N n (%) or 
mean (SD)
Age (years) 157 32.8 (5.5)* 1225 31.5 (5.7)
Smoking 157 14 (9%) 1220 63 (5%)
Alcohol 157 9 (6%) 1223 63 (5%)
Drug use 157 1 (0.6%) 1223 17 (1%)
Years in full-time education 147 14.4 (3.1)** 1122 13.5 (3.0)
Ethnic group
      White 157 139 (89%)** 1224 895 (73%)
      Black 157 8 (5%)** 1224 180 (15%)
      Asian 157 6 (4%) 1224 104 (8%)
      Mixed 157 3 (2%) 1224 28 (2%)
      Other 157 0 (0%) 1224 17 (1%)
Any previous pregnancy 154 147 (95%) 1224 1172 
(96%)
History of preterm birth (any) 154 121 (79%) 1223 966 (79%)
Demographics of participants in the pilot study group versus the complete 
OPPTIMUM trial cohort. Each field was analysed for statistical differences 
between these two groups. SD = standard deviation. * = p<0.05, ** = p<0.001, 
*** = p<0.0001
For the variable ‘gestation at birth’, concordance between 
self-recalled birth details and prospective trial birth details 
was improved in earlier gestations: 15/18 (83%) concordance 
for birth under 34 weeks, 27/34 (79%) for birth between 
34–36 weeks inclusive and 76/101 (75%) for birth at 37 weeks 
or later. 144/153 (94%) of respondents self-recalled a gestation 
of birth within 1 week of the data in the prospective trial 
and 149/156 (96%) self-recalled their age at birth within 
1 year of the prospective trial data.
Preterm birth
In prospectively collected trial data 52/157 (33%) respondents 
had a PTB. Of these, 15/52 (29%) women had a medically 
indicated preterm birth (i.e. induced labour, or elective caesarean 
section due to suspected fetal compromise, maternal condition 
or previous caesarean section). Onset of labour was spon-
taneous in the remaining 37/52 (71%) of women. In the 
prospectively collected trial data 11/37 (30%) of spontaneous 
PTBs were preceded by PPROM. There was concordance in 
the presence of PPROM between prospective trial birth details 
and self-recalled birth details in only 6/11 (55%) cases 
(Figure 2).
Smoking status, non-prescription drug use, alcohol 
consumption
There was no statistical difference found between the number 
of smokers reported in prospective trial data and self-recalled 
data (p=0.838). The difference in non-prescription drug use 
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Table 3. Concordance of prospective trial birth details with self-recalled pregnancy and birth details.
Number Missing self-
recall data
Missing prospective 
trial data
Concordance 95% Confidence 
Intervals
Mode of delivery 157 1 (0.6%) 154/156 
99%
95.4, 99.8
Smoking status 157 151/157 
96%
91.6, 98.6
Ethnicity 157 1 (0.6%) 149/156 
96%
91, 98.2
Labour onset 157 1 (0.6% 1 (0.6%) 142/155 
92%
86.1, 95.5
Drug use 157 1 (0.6%) 1 (0.6%) 136/155 
88%
81.5, 92.5
Alcohol use 157 1 (0.6%) 131/156 
84%
77.3, 89.4
Maternal age at birth 157 1 (0.6%) 126/156 
81%
73.7, 86.6
Gestation at birth 157 1 (0.6%) 3 (2%) 118/153 
77%
69.6, 83.5
Number of previous 
pregnancies
157 104/157 
66%
58.9, 74.2
Preterm premature 
rupture of membranes
11 6/11 
55%
23.4, 83.3
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Figure 2. Concordance of prospective trial birth details with self-recalled pregnancy and birth details for each of the questions in the 
participant questionnaire.
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between prospective trial data and self-recalled data was 
statistically significant (p=0.0001); 18/157 (11%) of women 
recorded as no drug use in prospective trial data classified 
themselves as having used non-prescription drugs during their 
pregnancy. A subset of these women (10/18, 56%) included 
the names of the drugs used; these included paracetamol, 
aspirin, folic acid, codeine and “indigestion medication”. The 
difference between alcohol consumption in prospective trial data 
and self-recalled data was statistically significant (p=0.0005); 
23/148 (16%) women recorded as non-drinkers in pro-
spective trial data self-recalled use of alcohol during their 
pregnancy.
Number of previous pregnancies
With regards to number of previous pregnancies, there was a 
discrepancy in 53/157 (34%) cases. In 30/53 (57%) of these, 
a higher number of previous pregnancies was recorded in 
prospective trial data than in self-recalled data.
Discussion
The primary aim of this study was to pilot postal dona-
tion of self-collected DNA samples from postpartum women 
and their babies. The recruitment rate of 23% was below our 
pre-specified response rate of ≥ 50% and compares poorly 
with other studies investigating self-collection of DNA which 
have had participation rates greater than 50%16,17. Only one 
reminder was sent - it is possible that further reminders might 
have increased the participation rate. We recruited partici-
pants from a cohort of women who had previously taken part in 
the OPPTIMUM trial. Although this limited our study popula-
tion, the main advantages were that consent had already been 
obtained and that high quality prospectively collected data on 
demographics and birth outcomes was available for validation.
The Preterm Birth Genome Project investigated multiple meth-
ods of DNA collection from mother and baby pairs (whole 
blood, blood spot, buccal, saliva) from four countries and found 
that samples were not affected by transportation methods and 
that salivary samples provided an adequate yield of DNA, 
superior to buccal swabs18. Similar studies of self-collected 
saliva samples report DNA yields of > 70%19,20. Our study 
shows that postal self-collected saliva samples from mothers and 
babies were of sufficient quality for genetic analysis but yields 
were variable.
We also aimed to determine the concordance between self-
recalled birth details and prospective trial birth details with a 
view to determine if postal questionnaires are a valid method of 
phenotyping PTB. We demonstrate that concordance was above 
the pre-specified 95% in only three out of ten questions. It is 
very unlikely that the prospectively collected OPPTIMUM 
trial data was erroneous. The study was carried out to rigor-
ous clinical trial standards with a pre-defined data dictionary and 
training of all research staff contributing to data collection. 
There was regular trial data monitoring from the sponsor 
ensuring data quality and consistency with checking of source 
data.
Labour onset and membrane rupture are important features 
which differentiate spontaneous PTB from PTB following 
PPROM and medically indicated PTB. This is crucial, as the 
underlying genetic basis for each phenotype is potentially 
different. In this dataset, concordance for labour onset was 
reasonably good at 92%. We assessed concordance for the 
occurrence of PPROM in women who had a PTB, which was 
low (despite wide confidence intervals), suggesting that PPROM 
is not accurately recalled. However, we recognise that this is a 
very small subset of women and a larger number would be 
required to accurately assess this finding.
We have demonstrated poor concordance between self-recalled 
birth details and prospective trial birth details with regards to age 
at birth, gestation at birth and number of previous pregnancies. 
Of note, the index birth was up to five years ago. Despite 
piloting and validating questionnaires, the accurate recall 
of time dependent features are still susceptible to recall bias 
and so this method may not be reliable for gathering critical 
information. Answers to such questions may also be dependent 
on the level of health or mathematic literacy in the study 
population, though the mean period in full-time education for 
this cohort was 14.4 years. In addition, the question asking 
about previous pregnancies fell on a page break which split the 
question (see extended data: Appendix 113). This led to some 
women incorrectly completing the question, confounding our 
results. This emphasises the importance of piloting a questionnaire 
in its completed, printed form.
Compared to the high level of concordance for smoking 
status, the concordance between prospective trial data and self-
recalled data was much lower with regards to non-prescription 
drug use and alcohol intake: a much higher level of alcohol 
consumption was reported in self-recalled data than in prospec-
tive trial data. Interestingly, the discrepancies between the report-
ing of smoking, alcohol and non-prescription drug use are in 
both directions. This highlights differences in public perception 
and willingness to disclose such information whilst in a research 
trial or in an anonymised questionnaire. The inconsistencies 
in reporting of non-prescription drug use were mainly due to 
several women self-recalling use of ‘over the counter’ medica-
tions such as paracetamol. This is in contrast to the OPPTIMUM 
trial definition of non-prescription drug use which included: 
heroin, cocaine or abuse of prescribed drugs such as benzodi-
azepines. This finding is most likely due to a misinterpretation 
of the question and further highlights the importance of accurate 
wording in similar questionnaire studies.
In conclusion, this feasibility study shows that women can suc-
cessfully collect DNA from themselves and their babies, but 
overall yields were variable. Yield from babies was lower than 
mothers due to the lower amount of saliva collected with the 
Oragene OG-575. Taqman genotyping showed the samples were 
suitable for variant calling and checking sex. The low yields, 
particularly for the baby samples, would make some methods 
of genomic analysis challenging, such as exome sequencing, 
but with the development of low-input kits even these methods 
Page 8 of 14
Wellcome Open Research 2020, 5:26 Last updated: 15 APR 2020
may be suitable. Consideration should be given to the genetic 
analysis to be performed when deciding on a collection method.
We found postal post-partum participation rates are low and 
there were significant discrepancies between self-recall of preg-
nancy and birth details and prospective birth details as recorded 
in the OPPTIMUM trial dataset. We conclude that informa-
tion gathered from postal questionnaires is insufficient to 
accurately phenotype PTB and clinical data collection from 
medical records needs to be an integral part of any future 
study design into the genetics of preterm birth.
Data availability
Underlying data
Figshare: Postal recruitment for genetic studies of preterm birth: 
A feasibility study. https://doi.org/10.6084/m9.figshare.788708313
This project contains the following underlying data:
-    Figshare1. DNA data.csv (Dataset showing total DNA yield 
for all self-collected samples)
-    Figshare2. OPPTIMUM trial data.csv (Prospective trial 
data)
-    Figshare3. Questionnaire data.csv (Data from participant 
questionnaires)
-    Figshare4. Comparison results of y markers_281019_
BABY.csv (Results of determining sex of baby from saliva 
samples)
-    Figshare5. Taqman Genotyping Report_291019.pdf (Report 
detailing results of Taqman genotyping)
-    Genotyping results for 6 x SNPs using mother and baby 
samples (individual files for Taqman genotyping results for 
mother and baby for each SNP: rs6427699, rs4751955, 
rs11083515, rs7588807, rs10938367 & rs10869955)
Extended data
Figshare: Postal recruitment for genetic studies of preterm birth: 
A feasibility study. https://doi.org/10.6084/m9.figshare.788708313
This project contains the following extended data:
-    Appendix 1. Participant questionnaire (example of partici-
pant questionnaire)
-    Appendix 2. OPPTIMUM trial inclusion and exclusion cri-
teria (list of inclusion and exclusion criteria for recruitment 
to the OPPTIMUM trial)
-    Appendix 3. List of recruitment pack contents (list of 
recruitment pack contents for women who had a live birth, 
and for women who had a stillbirth, neonatal or infant 
death)
-    OPPTIMUM Genetics invitation letters (invitation let-
ters to participate in OPPTIMUM Genetics study, one 
for women who had a live birth, one for women who had 
a stillbirth, neonatal or infant death)
-    Recruitment pack letters (letters included in recruit-
ment pack, one for women who had a live birth, one for 
women who had a stillbirth, neonatal or infant death)
-    OPPTIMUM genetics patient information leaflets (patient 
information leaflets, one for women who had a live 
birth, one for women who had a stillbirth, neonatal or 
infant death)
-    OPPTIMUM genetics consent forms (participant consent 
form, one for women who had a live birth including 
consent for her baby or child to participate, one for 
women who had a stillbirth, neonatal or infant death)
-    OPPTIMUM genetics child assent form (for children 
over 5 years of age to assent to participation in study)
-    Saliva sample collection instructions (instructions on 
how to collect saliva sample from participant and from 
baby or child using Oragene saliva kits)
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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